Share
Despite political and economic uncertainties, healthcare remains a lucrative investment space. However, growing concerns around government spending cuts on Medicare, Medicaid, and medical research could impact investment flows. Additionally, tariffs and high interest rates may influence deal valuations and financing conditions. Despite these risks, experts believe healthcare's fundamental value proposition—driven by necessity and innovation—will keep it attractive to investors in the long run.
Rob Larson was interviewed by Termgrid and shared his thoughts on the role and value of tech-enabled services, as well as some thoughts on the overall state of the market.
Read More
Rob Larson was featured by Bezinga, offering his expert insights on the current state of healthcare within PE and why investments continue to be made in the industry, Read more.
Partner Chen Liu attended CivStart's GovTech conference, sharing his insights and key takeaways on what GovTech providers and investors should know. Read more.
Grant Thornton Stax has released its annual Top 20 Ranking of Exhibition Organizers. Click here to explore the full list.
Global Practice Leader Paul Edwards explains how diligence is changing and how confidence and conviction are adding exit value. Read the full article here.
Rob Larson met with Carta to discuss the growing problem of supply and demand in the US healthcare system, and how a technological revamp could be necessary. Read the full feature here.
Grant Thornton Stax supported Outcomes, a leading provider of clinical network services and pharmacy technology, on its recent acquisition by H.I.G. Capital. Read more.